BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 2876711)

  • 1. The effect of kainic, quinolinic and beta-kainic acids on the release of endogenous amino acids from rat brain slices.
    Connick JH; Stone TW
    Biochem Pharmacol; 1986 Oct; 35(20):3631-5. PubMed ID: 2876711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quinolinic acid effects on amino acid release from the rat cerebral cortex in vitro and in vivo.
    Connick JH; Stone TW
    Br J Pharmacol; 1988 Apr; 93(4):868-76. PubMed ID: 2898959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kynurenic acid and quinolinic acid act at N-methyl-D-aspartate receptors in the rat hippocampus.
    Ganong AH; Cotman CW
    J Pharmacol Exp Ther; 1986 Jan; 236(1):293-9. PubMed ID: 2867215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quinolinic acid is a potent lipid peroxidant in rat brain homogenates.
    Rios C; Santamaria A
    Neurochem Res; 1991 Oct; 16(10):1139-43. PubMed ID: 1686636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [3H]norepinephrine release from hippocampal slices is an in vitro biochemical tool for investigating the pharmacological properties of excitatory amino acid receptors.
    Vezzani A; Wu HQ; Samanin R
    J Neurochem; 1987 Nov; 49(5):1438-42. PubMed ID: 2889798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of systemic kainate administration on cerebral quinolinic acid metabolism in the rat.
    Speciale C; Schwarcz R
    Exp Neurol; 1988 Jan; 99(1):213-8. PubMed ID: 2961590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kainic acid differentially affects the synaptosomal release of endogenous and exogenous amino acidic neurotransmitters.
    Poli A; Contestabile A; Migani P; Rossi L; Rondelli C; Virgili M; Bissoli R; Barnabei O
    J Neurochem; 1985 Dec; 45(6):1677-86. PubMed ID: 2865332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional and neurochemical cortical cholinergic impairment following neurotoxic lesions of the nucleus basalis magnocellularis in the rat.
    el-Defrawy SR; Coloma F; Jhamandas K; Boegman RJ; Beninger RJ; Wirsching BA
    Neurobiol Aging; 1985; 6(4):325-30. PubMed ID: 2935744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo microdialysis studies on the effects of decortication and excitotoxic lesions on kainic acid-induced calcium fluxes, and endogenous amino acid release, in the rat striatum.
    Butcher SP; Lazarewicz JW; Hamberger A
    J Neurochem; 1987 Nov; 49(5):1355-60. PubMed ID: 2889796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacology and regional variations of quinolinic acid-evoked excitations in the rat central nervous system.
    Perkins MN; Stone TW
    J Pharmacol Exp Ther; 1983 Aug; 226(2):551-7. PubMed ID: 6308211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential vulnerability of central neurons of the rat to quinolinic acid.
    Schwarcz R; Köhler C
    Neurosci Lett; 1983 Jul; 38(1):85-90. PubMed ID: 6225037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential sparing of somatostatin-neuropeptide Y and cholinergic neurons following striatal excitotoxin lesions.
    Beal MF; Kowall NW; Swartz KJ; Ferrante RJ; Martin JB
    Synapse; 1989; 3(1):38-47. PubMed ID: 2563916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quinolinic acid evokes [3H]acetylcholine release in striatal slices: mediation by NMDA-type excitatory amino acid receptors.
    Lehmann J; Schaefer P; Ferkany JW; Coyle JT
    Eur J Pharmacol; 1983 Dec; 96(1-2):111-5. PubMed ID: 6141057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potentiation by kainate of excitatory amino acid release in striatum: complementary in vivo and in vitro experiments.
    Young AM; Crowder JM; Bradford HF
    J Neurochem; 1988 Feb; 50(2):337-45. PubMed ID: 2891791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticonvulsant action of beta-kainic acid in mice. Is beta-kainic acid an N-methyl-D-aspartate antagonist?
    Turski L; Meldrum BS; Collins JF
    Brain Res; 1985 Jun; 336(1):162-6. PubMed ID: 2860949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of topically applied excitatory amino acids on evoked potentials and single cell activity in rat cerebral cortex.
    Addae JI; Stone TW
    Eur J Pharmacol; 1986 Mar; 121(3):337-43. PubMed ID: 2870932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Release of D-[3H]aspartic acid from the rat striatum. Effect of veratridine-evoked depolarization, fronto-parietal cortex ablation, and striatal lesions with kainic acid.
    Arqueros L; Abarca J; Bustos G
    Biochem Pharmacol; 1985 Apr; 34(8):1217-24. PubMed ID: 2581579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo release of [3H]-purines by quinolinic acid and related compounds.
    Perkins MN; Stone TW
    Br J Pharmacol; 1983 Oct; 80(2):263-7. PubMed ID: 6317129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The response of striatal neuropeptide Y and cholinergic neurons to excitatory amino acid agonists.
    Boegman RJ; Parent A
    Brain Res; 1988 Jun; 452(1-2):219-26. PubMed ID: 2900050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Idebenone attenuates neuronal degeneration induced by intrastriatal injection of excitotoxins.
    Miyamoto M; Coyle JT
    Exp Neurol; 1990 Apr; 108(1):38-45. PubMed ID: 2138566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.